AU2011201462B2 — Method of Administering Pirfenidone Therapy
Assigned to Intermune Inc · Expires 2016-09-29 · 10y expired
What this patent protects
The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes. -C -AA 4* **AAA "AA < 0 o 100 *000A Study Day -~50 0) AA A *AA C: 40- AtAAA >% 30- **A ,AA x AAA…
USPTO Abstract
The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes. -C -AA 4* **AAA "AA < 0 o 100 *000A Study Day -~50 0) AA A *AA C: 40- AtAAA >% 30- **A ,AA x AAA 0:::AAA **0 *000 AA )20- *OOAA Study Day Figure 1
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.